Palbace 125 mg (Palbociclib)
Price range: $2,910 through $8,190Palbace (Palbociclib Capsules) contains palbociclib, an oral CDK4/6 inhibitor used alongside endocrine therapy for hormone receptor–positive, HER2-negative advanced or metastatic breast cancer. Taken in 21-day cycles (21 days on, 7 days off), Palbace helps slow cancer progression and prolongs progression-free survival under oncologist supervision.

